Literature DB >> 24013776

Reprogramming and genome integrity: role of non-homologous end joining.

P Salomoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24013776      PMCID： PMC3770320          DOI： 10.1038/cdd.2013.95

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  7 in total

Review 1.  Mechanism and regulation of human non-homologous DNA end-joining.

Authors:  Michael R Lieber; Yunmei Ma; Ulrich Pannicke; Klaus Schwarz
Journal:  Nat Rev Mol Cell Biol       Date:  2003-09       Impact factor: 94.444

2.  Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells.

Authors:  Sun Yung; Maria Ledran; Inmaculada Moreno-Gimeno; Ana Conesa; David Montaner; Joaquín Dopazo; Ian Dimmick; Nicholas J Slater; Lamin Marenah; Pedro J Real; Iliana Paraskevopoulou; Viviana Bisbal; Deborah Burks; Mauro Santibanez-Koref; Ruben Moreno; Joanne Mountford; Pablo Menendez; Lyle Armstrong; Majlinda Lako
Journal:  Hum Mol Genet       Date:  2011-09-21       Impact factor: 6.150

3.  XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.

Authors:  Peter Ahnesorg; Philippa Smith; Stephen P Jackson
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

4.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.

Authors:  Rosa M Marión; Katerina Strati; Han Li; Matilde Murga; Raquel Blanco; Sagrario Ortega; Oscar Fernandez-Capetillo; Manuel Serrano; Maria A Blasco
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  Genomic instability in induced stem cells.

Authors:  C E Pasi; A Dereli-Öz; S Negrini; M Friedli; G Fragola; A Lombardo; G Van Houwe; L Naldini; S Casola; G Testa; D Trono; P G Pelicci; T D Halazonetis
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

6.  DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.

Authors:  K M Frank; N E Sharpless; Y Gao; J M Sekiguchi; D O Ferguson; C Zhu; J P Manis; J Horner; R A DePinho; F W Alt
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

7.  A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors.

Authors:  K Tilgner; I Neganova; I Moreno-Gimeno; J Y Al-Aama; D Burks; S Yung; C Singhapol; G Saretzki; J Evans; V Gorbunova; A Gennery; S Przyborski; M Stojkovic; L Armstrong; P Jeggo; M Lako
Journal:  Cell Death Differ       Date:  2013-05-31       Impact factor: 15.828
  7 in total
  2 in total

Review 1.  Stem cells: the pursuit of genomic stability.

Authors:  Saranya P Wyles; Emma B Brandt; Timothy J Nelson
Journal:  Int J Mol Sci       Date:  2014-11-14       Impact factor: 5.923

Review 2.  DNA repair and aging: the impact of the p53 family.

Authors:  Sara Nicolai; Antonello Rossi; Nicola Di Daniele; Gerry Melino; Margherita Annicchiarico-Petruzzelli; Giuseppe Raschellà
Journal:  Aging (Albany NY)       Date:  2015-12       Impact factor: 5.682
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.